Skip to content

Efficacy of Dexamethasone in reducing pain, nausea and vomiting, improve mobilisation and reduce hospital stay in hip and knee arthroplasty: a double blind controlled trial

Efficacy of Dexamethasone in reducing pain, nausea and vomiting, improve mobilisation and reduce hospital stay in hip and knee arthroplasty: a double blind controlled trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000540516
Acronym
DexPO
Enrollment
142
Registered
2015-05-27
Start date
2015-06-04
Completion date
2017-10-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to determine if steroids used at the time of surgery reduce pain, nausea and vomiting, and reduce length of stay in patients undergoing total hip or knee arthroplasty procedures.

Interventions

Two doses of 8mg of dexamethasone are given intravenously. The first dose is given immediately pre-operatively and the second dose given 24 hours post surgery. The syringe with the Dexamethasone will be provided to the operating room and ward by the pharmacy.

Sponsors

Jonathan Mulford
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

- People who are presenting to preadmission clinic for single joint hip or knee arthroplasty. - Able to provide informed consent - Age 18 years and older

Exclusion criteria

- Type 1 or type 2 diabetes mellitus; renal failure; hepatic failure - Use of oral corticosteroids over past 6 months - Allergic or adverse reaction to corticosteroids in the past - Allergy to the food preservative Sulfite (this does not include Sulpha containing medications) - Active peptic ulcer disease with symptoms present in the previous 6 months - Previous GIT haemorrhage - Pregnancy and lactation - Past history of psychotic illness (including psychotic depression) - Current systemic fungal infection - Administration of live vaccine in the previous 3 months - Myasthenia gravis

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026